- Investigator
- Melissa E Elder
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- T-Lymphocytes , 7 publications
- Severe Combined Immunodeficiency , 7 publications
- Rituximab , 6 publications
- Autoantibodies , 6 publications
Research activity
Active clinical trials
- Investigator
- Melissa E Elder
- Status
- Accepting Candidates
My publications
Filter publications
51 publications
2023
Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.
Molecular therapy. Methods & clinical development
鈥�2023
Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases.
Clinical rheumatology
鈥�2023
Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.
Frontiers in pediatrics
鈥�2023
Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus.
Clinical and experimental rheumatology
鈥�2022
Secondary hemophagocytic lymphohistiocytosis following Zolgensma therapy: An evolving story on the innate response to systemic gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy
鈥�